214 related articles for article (PubMed ID: 38037913)
41. Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.
Lakey-Beitia J; Burillo AM; La Penna G; Hegde ML; Rao KS
J Alzheimers Dis; 2021; 82(s1):S335-S357. PubMed ID: 32568200
[TBL] [Abstract][Full Text] [Related]
42. Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.
Adhihetty PJ; Beal MF
Neuromolecular Med; 2008; 10(4):275-90. PubMed ID: 19005780
[TBL] [Abstract][Full Text] [Related]
43. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
44. The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders I: Parkinson's disease.
Campos HC; da Rocha MD; Viegas FP; Nicastro PC; Fossaluzza PC; Fraga CA; Barreiro EJ; Viegas C
CNS Neurol Disord Drug Targets; 2011 Mar; 10(2):239-50. PubMed ID: 20874702
[TBL] [Abstract][Full Text] [Related]
45. Stalling the Course of Neurodegenerative Diseases: Could Cyanobacteria Constitute a New Approach toward Therapy?
Ramos V; Reis M; Ferreira L; Silva AM; Ferraz R; Vieira M; Vasconcelos V; Martins R
Biomolecules; 2023 Sep; 13(10):. PubMed ID: 37892126
[TBL] [Abstract][Full Text] [Related]
46. Role of Sirtuin 3 in Degenerative Diseases of the Central Nervous System.
Zhang H; Dai S; Yang Y; Wei J; Li X; Luo P; Jiang X
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238605
[TBL] [Abstract][Full Text] [Related]
47. Emerging Potential of Naturally Occurring Autophagy Modulators Against Neurodegeneration.
Rahman MA; Rahman MR; Zaman T; Uddin MS; Islam R; Abdel-Daim MM; Rhim H
Curr Pharm Des; 2020; 26(7):772-779. PubMed ID: 31914904
[TBL] [Abstract][Full Text] [Related]
48. Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.
Bhullar KS; Rupasinghe HP
Oxid Med Cell Longev; 2013; 2013():891748. PubMed ID: 23840922
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.
Cooper GJ
Drugs; 2011 Jul; 71(10):1281-320. PubMed ID: 21770477
[TBL] [Abstract][Full Text] [Related]
50. Mitochondrial metals as a potential therapeutic target in neurodegeneration.
Grubman A; White AR; Liddell JR
Br J Pharmacol; 2014 Apr; 171(8):2159-73. PubMed ID: 24206195
[TBL] [Abstract][Full Text] [Related]
51. Copper in diseases and treatments, and copper-based anticancer strategies.
Tisato F; Marzano C; Porchia M; Pellei M; Santini C
Med Res Rev; 2010 Jul; 30(4):708-49. PubMed ID: 19626597
[TBL] [Abstract][Full Text] [Related]
52. Reorganizing metals: the use of chelating compounds as potential therapies for metal-related neurodegenerative disease.
Badrick AC; Jones CE
Curr Top Med Chem; 2011; 11(5):543-52. PubMed ID: 21189128
[TBL] [Abstract][Full Text] [Related]
53. Role of manganese in neurodegenerative diseases.
Bowman AB; Kwakye GF; Herrero Hernández E; Aschner M
J Trace Elem Med Biol; 2011 Dec; 25(4):191-203. PubMed ID: 21963226
[TBL] [Abstract][Full Text] [Related]
54. Is there a role for copper in neurodegenerative diseases?
Cerpa W; Varela-Nallar L; Reyes AE; Minniti AN; Inestrosa NC
Mol Aspects Med; 2005; 26(4-5):405-20. PubMed ID: 16112188
[TBL] [Abstract][Full Text] [Related]
55. Targeting Protein Aggregates with Natural Products: An Optional Strategy for Neurodegenerative Diseases.
Xiang L; Wang Y; Liu S; Liu B; Jin X; Cao X
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511037
[TBL] [Abstract][Full Text] [Related]
56. Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease.
Perez LR; Franz KJ
Dalton Trans; 2010 Mar; 39(9):2177-87. PubMed ID: 20162187
[TBL] [Abstract][Full Text] [Related]
57. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.
Mandel SA; Avramovich-Tirosh Y; Reznichenko L; Zheng H; Weinreb O; Amit T; Youdim MB
Neurosignals; 2005; 14(1-2):46-60. PubMed ID: 15956814
[TBL] [Abstract][Full Text] [Related]
58. Neurochemical correlation between major depressive disorder and neurodegenerative diseases.
Réus GZ; Titus SE; Abelaira HM; Freitas SM; Tuon T; Quevedo J; Budni J
Life Sci; 2016 Aug; 158():121-9. PubMed ID: 27370938
[TBL] [Abstract][Full Text] [Related]
59. Mechanistic new insights of flavonols on neurodegenerative diseases.
Tahir MS; Almezgagi M; Zhang Y; Bashir A; Abdullah HM; Gamah M; Wang X; Zhu Q; Shen X; Ma Q; Ali M; Solangi ZA; Malik WS; Zhang W
Biomed Pharmacother; 2021 May; 137():111253. PubMed ID: 33545661
[TBL] [Abstract][Full Text] [Related]
60. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases.
Mandel S; Weinreb O; Amit T; Youdim MB
J Neurochem; 2004 Mar; 88(6):1555-69. PubMed ID: 15009657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
